Jeffrey Fudin, PharmD, FCCP, FASHP, FFSMB

Pharmacists can extend education to prescribers and provide important guidance on abuse-deterrent opioid formulations.

Patients on this therapy should monitor their INR frequently, especially when adding other medications.

Medications in this drug class can alter the safety and efficacy of co-administered medications.

Calcitonin gene-related peptide inhibitors are integral to preventing these powerful headaches.

Clinicians should weigh the risks and benefits of each medication to ensure effective and safe care.

Despite data that might suggest a drug interaction, clinical significance is the deciding factor when considering therapeutic benefit over risk.